Tue, April 14, 2020

Jason Mills Maintained (TMDX) at Strong Buy with Decreased Target to $19 on, Apr 14th, 2020

Jason Mills of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Decreased Target from $20 to $19 on, Apr 14th, 2020.

Jason has made no other calls on TMDX in the last 4 months.



There are 2 other peers that have a rating on TMDX. Out of the 2 peers that are also analyzing TMDX, 1 agrees with Jason's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $16 on, Wednesday, March 4th, 2020


This is the rating of the analyst that currently disagrees with Jason


  • Suraj Kalia of "Oppenheimer" Initiated at Buy and Held Target at $25 on, Tuesday, April 7th, 2020